Vlad Sandulache, M.D. Ph.D. Photo

Vlad Sandulache, M.D. Ph.D.

Associate Professor
Baylor College of Medicine

Request Clinical Appointment

Position

Address

Jamail Specialty Care Center (Clinic)
1977 Butler Blvd.
Suite E5.200
5th floor
Houston, Texas 77030
United States
(713) 798-5900
Google Maps

Certifications

  • Diplomate
    American Board of Otolaryngology-Head and Neck Surgery

Education

  • MD-PhD from University of Pittsburgh School of Medicine
    05/2008 - Pittsburgh United States
  • Residency at Baylor College of Medicine, Department of Otolaryngology Head and Neck Surgery
    06/2015 - Houston, Texas United States
  • Clinical Fellowship at University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery
    06/2016 - Houston, Texas United States

Language

Professional Statement

Vlad C. Sandulache MD, PhD is a board certified otolaryngologist specializing in Head and Neck Surgical Oncology. Dr. Sandulache earned his MD and PhD from the University of Pittsburgh, and completed his residency in Otolaryngology Head and Neck Surgery at Baylor College of Medicine. Following residency, Dr. Sandulache completed a clinical fellowship in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center where he received advanced training in minimally invasive surgical techniques for pharyngeal and laryngeal malignancies including transoral robotic surgery (TORS) and transoral laser surgery. Dr. Sandulache utilizes a multidisciplinary approach to the management of patients with head and neck cancer with active participation in both surgical and non-surgical clinical trials. His primary clinical expertise is in the management of early and advanced stage oropharyngeal and laryngeal cancer, salivary gland neoplasms and poorly differentiated and anaplastic thyroid carcinoma. Dr. Sandulache maintains an active basic science and clinical research program focused on elucidating the link between cancer metabolism and treatment effectiveness. The goal of this research program is to develop personalized treatment strategies based on tumor genomic information and metabolic response to conventional and targeted treatment strategies. One application of this approach currently underway is development of more effective treatments for poorly differentiated and anaplastic thyroid carcinoma.

Professional Interests

  • Laryngeal and pharyngeal cancer
  • Thyroid cancer
  • Salivary gland neoplasm
  • Melanoma
  • Advanced skin cancer

Physician Specialties

  • Cancer Care
  • Head and Neck Cancer
  • Thyroid Surgery
  • Otolaryngology
  • Cancer survivorship

Memberships

  • American Head and Neck Society
    06/2015

Websites